ERG gene rearrangements are common in prostatic small cell carcinomas. - Wikidata - awgldk - TriplyDB

ERG gene rearrangements are common in prostatic small cell carcinomas.

ERG gene rearrangements are common in prostatic small cell carcinomas.

http://www.wikidata.org/entity/Q41628946

about

Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for intervention Molecular aspects of prostate cancer with neuroendocrine differentiation PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer The many faces of neuroendocrine differentiation in prostate cancer progression Distinct genetic alterations in small cell carcinoma from different anatomic sites Targeting the adaptive molecular landscape of castration-resistant prostate cancer N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer Severe Cushing's syndrome due to small cell prostate carcinoma: a case and review of literature.Frequent discordance between ERG gene rearrangement and ERG protein expression in a rapid autopsy cohort of patients with lethal, metastatic, castration-resistant prostate cancer.Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins Polycomb-mediated silencing in neuroendocrine prostate cancer.Integrative molecular profiling of routine clinical prostate cancer specimens.Neuroendocrine Tumors of the Prostate: Emerging Insights from Molecular Data and Updates to the 2016 World Health Organization Classification.Comprehensive serial molecular profiling of an "N of 1" exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment miR-539 inhibits prostate cancer progression by directly targeting SPAG5 Nucleotide resolution analysis of TMPRSS2 and ERG rearrangements in prostate cancer.Genitourinary small-cell carcinoma: a single-institution experience HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey Review of small cell carcinomas of the prostate.Histological variants of prostatic carcinoma and their significance.Diagnostic and prognostic molecular biomarkers for prostate cancer.ERG protein expression as a biomarker of prostate cancer.Small cell carcinoma of the prostate.Characterization of prostate neuroendocrine cancers and therapeutic management: a literature review.Neuroendocrine differentiation of prostate cancer: a review.ERG expression in prostate cancer: biological relevance and clinical implication.Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance.High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer.Genomic predictors for treatment of late stage prostate cancer.Drug discovery in advanced prostate cancer: translating biology into therapy.Emerging trends in the evaluation and management of small cell prostate cancer: a clinical and molecular perspective.TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation.Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer.Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma.Emerging Variants of Castration-Resistant Prostate Cancer.Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer--a comparative study of two monoclonal antibodies.Next generation patient-derived prostate cancer xenograft models.

P2860

Q21129293-1F962150-5C78-4085-B467-32FD03364D0E Q26752910-B809059E-3272-4AE0-B429-AF98BF548727 Q26752933-30E05036-9A07-4B5A-AAE7-C81EC0FBBF22 Q26777310-273010A2-E2F9-4255-8A6F-B07E1383A42D Q26992049-7C6AA243-0A8A-4318-A08B-3506D4E616CA Q27008242-66B0CB66-C67F-49FB-97BB-8A1BF5FA3C2C Q27022821-D6DA1A33-3FD4-44D6-8F9C-508F3A0A9B7F Q28771715-FEFD658F-B652-4F3F-B240-29EBE6B2BBCD Q33904201-62471E37-1B75-4968-8C3A-C6DDDB44D39C Q34143112-62C7FDF2-68C3-4D5D-9C4E-73CB2BD282D9 Q34216236-3E801B29-9B43-44A1-B938-0C617F0D26A2 Q34469034-AD17D55C-19A5-4494-A10A-EAE99E44B33B Q35336915-36E583D4-D779-4AE4-B4C9-CC42CCB82951 Q35892022-5F8D884A-CFCC-4178-A65F-59817D39751E Q35925835-CEB1E859-9E7D-465A-9911-E3972367F438 Q36131601-644D410E-63A1-4B52-B43C-00D077778E9A Q36758507-38C133D1-3D5F-40F3-BAF4-9F61153E4BCE Q36888450-27EEA78E-0524-4A1E-A4D7-4AEF67AD4BE9 Q37247963-5AB67DE7-39F9-41B7-B865-4F0FDCFEE438 Q37705596-EE42BAF5-AED7-40A3-A614-B259C92D75DC Q37960020-1FD780E7-ABAD-4027-BC4C-7C39E967D8CE Q37972700-737A207D-0854-4865-AA43-0D744C05C3A3 Q37972703-E966766C-CF1C-4934-88F8-DF5D48C1AF12 Q38165243-1238D5B8-5115-4AF2-BE13-1C180C230BCC Q38188869-97032E67-B4B1-416D-A774-3DDE235D4CB8 Q38209356-9700C3E5-1E5A-473F-BBC8-373B9FEA7DFB Q38326554-905ABB31-6F4A-45DF-9846-E471739C6C32 Q38681610-5FFC07DC-84EE-4D8D-8B5F-5264DB1E8DB9 Q38722705-FAC95236-E54B-4391-9EC4-21E897548B94 Q38737037-D3E78B7D-115A-416C-975D-2A9E15000C30 Q38794112-46395542-F837-4B01-AC71-9A4A593A4FF7 Q38839110-229CF495-6FB6-4708-8343-347D7D16A010 Q38930155-552E083F-CA08-49B4-BA2B-7B219DA1CC72 Q38952586-01088AED-016A-4C62-915F-FE452F554D61 Q39016544-537BA2CB-984A-4944-858B-D1BFAF27D727 Q39044979-4D7AF22E-A3D1-4F23-ADEB-92CDCFC83032 Q39210257-D324D3ED-B513-46B6-8E1F-408BE1B535A9 Q39385550-0D176111-4D5B-4369-8CA2-944B1FE54694 Q39666134-0039D445-A86C-439E-8E65-25CD44404821 Q39673894-B557961F-AA42-47A6-97CE-F8B8A68BFC18

P2860

ERG gene rearrangements are common in prostatic small cell carcinomas.

http://www.wikidata.org/entity/Q41628946

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

ERG gene rearrangements are common in prostatic small cell carcinomas.

@en

type

label

ERG gene rearrangements are common in prostatic small cell carcinomas.

@en

prefLabel

ERG gene rearrangements are common in prostatic small cell carcinomas.

@en

P1433

Q41628946-40349B29-2BDC-42FA-B359-9F98BEA3D51D

P1476

Q41628946-43942CB7-E58A-45CC-AE34-5AD629F2C71C

P2093

Q41628946-047C9E10-45CE-46CF-A7F0-86D9228FB880

Q41628946-15CE9D1B-0631-4C89-B587-FB38E9B8DFB7

Q41628946-25FAE2DC-04CA-489F-A9F5-1B83A8145D47

Q41628946-2C845DBA-37B5-4FF9-A4ED-4E2B87B7D59A

Q41628946-329E6EE1-56DB-43C7-BE53-73223D9C4C82

Q41628946-3E85E001-A4FA-4F2D-A81A-99B1904D30E0

Q41628946-4A180F59-4DAF-45C7-BE25-F8AF5FED4F4A

Q41628946-96CABDFD-684A-4BF7-A041-541C568B72DB

Q41628946-C8717361-7E85-4A59-919B-B881EC2AF8AC

Q41628946-E3A8490D-3F23-429E-B929-8D0B6C2D9D3C

P2860

Q41628946-0104CA71-B5EE-449C-9036-F1A4DE08B1C5

Q41628946-04B003D6-4D8B-4D67-A530-81083C31D88C

Q41628946-0B0149B6-16B4-452F-85E5-D2D8DA0C0B7C

Q41628946-117257DE-31C6-432D-9D53-7A930C780EF8

Q41628946-16FD89CD-D01D-4477-8DEF-B88E6BEA134A

Q41628946-1D36DC5F-B1B6-44BC-8BC8-9C7F90CC5A3C

Q41628946-23FD79FB-EAC0-48AE-81AD-3A6BD7E09036

Q41628946-3E28B881-090D-4162-A39C-1549F4D677E3

Q41628946-478C903A-0E2D-4B19-B848-605C909B1E12

Q41628946-51808637-38C8-41D5-B441-88408A7545B5

P2888

Q41628946-280264B5-E585-499E-839F-4EF89FA9601A

P304

Q41628946-F5D156CA-59EF-4945-B11A-368D0BF03D5C

P31

Q41628946-9AAE92F9-A535-41EA-839F-1F04CA30A809

P356

Q41628946-1D1850BE-91EA-4B6B-8D33-133D6D70E043

P433

Q41628946-51CBC3A8-E0F8-41F3-9FD5-D5E6DA56215B

P478

Q41628946-2B98D147-D953-4594-968E-02C27D83B5F5

P50

Q41628946-48119CDC-D597-4D6B-A505-79EF696776EE

Q41628946-8156F92C-FD67-4A8E-8CF8-3CC93948D3DA

P577

Q41628946-15B49707-4773-4F44-BF40-1A203144CFC0

P5875

Q41628946-151E4DF6-0D3A-430C-A289-3D59D97D9A7E

P6179

Q41628946-4F909A95-030A-4C3A-A117-3C9F2C2EAB36

P698

Q41628946-89A330D1-91CB-4485-B484-FA4FA40B61E3

P932

Q41628946-CF195221-ECAA-4383-ABD9-4D3B1972E221

P356

MODPATHOL.2011.7

P1433

Modern Pathology

P1476

ERG gene rearrangements are common in prostatic small cell carcinomas.

@en

P2093

Alan K Meeker

http://www.w3.org/2001/XMLSchema#string

Angelo M De Marzo

http://www.w3.org/2001/XMLSchema#string

Antoun Toubaji

http://www.w3.org/2001/XMLSchema#string

Charles J Bieberich

http://www.w3.org/2001/XMLSchema#string

George J Netto

http://www.w3.org/2001/XMLSchema#string

Jessica L Hicks

http://www.w3.org/2001/XMLSchema#string

Jonathan I Epstein

http://www.w3.org/2001/XMLSchema#string

Michael C Haffner

http://www.w3.org/2001/XMLSchema#string

Nilesh S Gupta

http://www.w3.org/2001/XMLSchema#string

Wenle Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.

Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate.

Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate.

TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.

Small cell carcinoma of the prostate: an immunohistochemical study.

Induced chromosomal proximity and gene fusions in prostate cancer.

Small cell carcinoma of prostate: effectiveness of hormonal versus chemotherapy.

TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features.

ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor.

P2888

modpathol.2011.7

P304

820-828

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2011.7

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49850485

http://www.w3.org/2001/XMLSchema#string

P6179

1035407645

http://www.w3.org/2001/XMLSchema#string

P698

21336263

http://www.w3.org/2001/XMLSchema#string

P932

3484363

http://www.w3.org/2001/XMLSchema#string